Extract
Bentley Pharmaceuticals Reports Second Quarter Results.
Revenues Increase 8% Amid Spanish Price Reductions
Company moves closer to extending patent protection on Testim[R] EXETER, N.H. -- Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today reported financial results for the three and six months ended June 30, 2007. Bentley's consolidated revenues increased 8% to $31.2 million from $29.0 million reported in the second quarter of 2006. Bentley's results in the second quarter of 2007 reflect the impact of a full quarter of reduced selling prices on the Company's Spanish pharmaceutical products. Price reductions were implemented by...See the full content of this document
Sponsored links
